Participants 0 92 4
Prevention of regimen-related toxicities after bone marrow transplantation by pentoxifylline
Participants 282 315 4
bone marrow transplantation (BMT)
Participants 521 544 6
patients undergoing BMT
Participants 611 689 8
140 patients undergoing either allogeneic (n = 51) or autologous BMT (n = 89).
